Key result
Delta neutrophil index at initial admission predicted poor prognosis in acute gastrointestinal diseases with a diagnostic.82.
Why the study?
Data on optimal measurement time were scarce, and no studies had evaluated the potential role of DNI as a prognostic biomarker of gastrointestinal diseases using diagnostic test accuracy meta-analysis.
Does the Delta neutrophil index (DNI) predict prognosis in patients with acute gastrointestinal diseases?
Meta-Analysis
Does the Delta neutrophil index (DNI) predict prognosis in patients with acute gastrointestinal diseases?
The Delta neutrophil index measured at initial admission is a reliable biomarker for predicting poor prognosis in patients with acute gastrointestinal diseases.
Answers are grounded in this paper and cite their sources.
Supports DNI for early risk stratification in acute GI diseases; extends pooled evidence but requires prospective validation before practice change.
Delta neutrophil index (DNI) is a novel diagnostic and prognostic biomarker of various infectious or inflammatory conditions. However, data on optimal measurement time are scarce, and no studies have evaluated the potential role of the DNI as a prognostic biomarker of gastrointestinal diseases with diagnostic test accuracy meta-analysis. Core databases were searched. The inclusion criteria were as follows: patients who have gastrointestinal diseases and DNI measurements presenting diagnostic indices for predicting the prognosis, including severity, surgical outcomes, and mortality from gastrointestinal diseases. We identified twelve studies for the systematic review and ten studies for the quantitative analysis. Pooled area under the curve, sensitivity, specificity, and diagnostic odds ratio of DNI at the initial admission date were 0.82 (95% confidence interval: 0.78-0.85), 0.75 (0.52-0.89), 0.76 (0.63-0.86), and 10 (3-35), respectively. Meta-regression showed no reasons for heterogeneity and publication bias was not detected. Fagan's nomogram indicated that the posterior probability of 'poor prognosis' was 76% if the test was positive, and 'no poor prognosis' was 25% if the test was negative. The DNI can be considered as a reliable initial measurement biomarker for predicting prognosis in patients with gastrointestinal diseases.
No takes yet. Share an insight, caveat, or question.
Jeong et al. (2020) conducted a meta-analysis in Acute Gastrointestinal Diseases. Delta neutrophil index (DNI) was evaluated on Prognosis (including severity, surgical outcomes, and mortality) (diagnostic OR 10, 95% CI 3-35). Delta neutrophil index at initial admission predicted poor prognosis in acute gastrointestinal diseases with a diagnostic.82.
Synapse has enriched 10 related papers. Consider them for comparative context: